Evolus Inc (NASDAQ: EOLS) on Thursday, soared 6.73% from the previous trading day, before settling in for the closing price of $10.11. Within the past 52 weeks, EOLS’s price has moved between $8.67 and $17.82.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 51.00% over the past five years. The company achieved an average annual earnings per share of 30.29%. With a float of $56.11 million, this company’s outstanding shares have now reached $63.50 million.
Let’s look at the performance matrix of the company that is accounted for 332 employees. In terms of profitability, gross margin is 67.4%, operating margin of -11.73%, and the pretax margin is -18.69%.
Evolus Inc (EOLS) Insider Updates
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Evolus Inc is 11.76%, while institutional ownership is 82.35%. The most recent insider transaction that took place on Mar 27 ’25, was worth 77,512. In this transaction an insider of this company sold 6,251 shares at a rate of $12.40, taking the stock ownership to the 508,619 shares. Before that another transaction happened on Mar 18 ’25, when Company’s insider sold 27,904 for $13.26, making the entire transaction worth $369,868. This insider now owns 362,467 shares in total.
Evolus Inc (EOLS) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 30.29% per share during the next fiscal year.
Evolus Inc (NASDAQ: EOLS) Trading Performance Indicators
Evolus Inc (EOLS) is currently performing well based on its current performance indicators. A quick ratio of 2.21 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach 0.61 in one year’s time.
Technical Analysis of Evolus Inc (EOLS)
Evolus Inc (NASDAQ: EOLS) saw its 5-day average volume 1.12 million, a positive change from its year-to-date volume of 0.88 million. As of the previous 9 days, the stock’s Stochastic %D was 67.77%. Additionally, its Average True Range was 0.86.
During the past 100 days, Evolus Inc’s (EOLS) raw stochastic average was set at 25.09%, which indicates a significant decrease from 55.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.16% in the past 14 days, which was higher than the 69.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.78, while its 200-day Moving Average is $13.52. Nevertheless, the first resistance level for the watch stands at $11.07 in the near term. At $11.34, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.71. If the price goes on to break the first support level at $10.42, it is likely to go to the next support level at $10.05. Assuming the price breaks the second support level, the third support level stands at $9.77.
Evolus Inc (NASDAQ: EOLS) Key Stats
Market capitalization of the company is 686.10 million based on 63,587K outstanding shares. Right now, sales total 266,270 K and income totals -50,420 K. The company made 78,950 K in profit during its latest quarter, and -6,790 K in sales during its previous quarter.
